Assessment of Two Levels of Arterial Pressure on Survival in Patients With Septic Shock
NCT01149278 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800
Last updated 2012-11-05
Summary
The ideal mean arterial pressure in patients with septic shock is unknown. The expert's recommandations have stated a target between 65 and 70 mm Hg. However the scientific basis are weak. Indead there are only few prospective studies which addressed this question without clear answer. Therefore we designed a RCT in order to assess the effect on mortality of two levels of mean arterial pressure in patients with septic shock.(800 patients, 30 centres)
Conditions
- Septic Shock
- Arterial Pressure
- Hemodynamics
- Mortality
- Clinical Trial
Interventions
- DRUG
-
maintain mean arterial pressure between 80-85 mm Hg
protocolized hemodynamic care aiming to maintain mean arterial pressure between 80-85 mm Hg
- OTHER
-
maintain mean arterial pressure between 65-70 mm Hg
protocolized hemodynamic care aiming to maintain mean arterial pressure between 65-70 mm Hg
Sponsors & Collaborators
-
University Hospital, Angers
lead OTHER_GOV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-03-31
- Primary Completion
- 2012-09-30
- Completion
- 2012-09-30
Countries
- France
Study Locations
More Related Trials
-
Personalized Mean Arterial Pressure Management on Renal Function During Septic Shock
NCT01473498 ·Status: TERMINATED ·Phase: NA
-
Efficacy of Targeted Abdominal Perfusion Pressure in Septic Shock
NCT05358912 ·Status: COMPLETED ·Phase: PHASE4
-
Microcirculation After MAP Increase in Septic Shock Patients With Previous Hypertension
NCT02519699 ·Status: COMPLETED ·Phase: PHASE4
-
Serum Rennin Kinetics Versus Serum Lactate Kinetics as Predictors of Mortality in Septic Shock Patients
NCT05327881 ·Status: UNKNOWN
-
Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock
NCT06122987 ·Status: RECRUITING ·Phase: PHASE4
-
Prospective Validation of Clini-biological Parameters Including Initial Hemostasis, Which Improve the Prediction of Death at 1 Month Among Patients With Septic Shock
NCT01231672 ·Status: COMPLETED
-
Protocol-driven Hemodynamic Support for Patients With Septic Shock
NCT00335907 ·Status: UNKNOWN ·Phase: NA
-
Hyperoxia and Hypertonic Saline in Septic Shock
NCT01722422 ·Status: TERMINATED ·Phase: NA
-
Effects of Fludrocortisone on Norepinephrine-mean Arterial Pressure Dose-response in Septic Shock
NCT02069288 ·Status: WITHDRAWN ·Phase: PHASE3
-
Fever Control Using External Cooling in Mechanically Ventilated Patients With Septic Shock
NCT04494074 ·Status: RECRUITING ·Phase: NA
-
Modulation of Vasoreactivity in Septic Shock: Impact of Recombinant Protein C
NCT02885168 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock
NCT06746753 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Venous to Arterial Carbon Dioxide Difference (P₍ᵥ-ₐ₎CO₂): Predictor of Septic Patient Prognosis Depending on the ScvO₂
NCT03292120 ·Status: COMPLETED ·Phase: NA
-
External Cooling in Septic Shock Patients
NCT00527007 ·Status: COMPLETED ·Phase: NA
-
Comparison of Radial and Femoral Artery Site Invasive Blood Pressure Measurement in Septic Shock Patients
NCT03475667 ·Status: COMPLETED
-
Correlation of VEGF-A and Fluid Balance in Septic Shock
NCT04474431 ·Status: COMPLETED ·Phase: NA
-
Investigating FE 202158 as Potential Primary Treatment in Patients With Early Septic Shock
NCT01612676 ·Status: COMPLETED ·Phase: PHASE2
-
Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic Shock
NCT00279214 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Plasma Angiotensin II and Angiotensin II Receptor Levels in Patients With Sepsis and Septic Shock: a Prospective Observational Study.
NCT04716842 ·Status: UNKNOWN
-
Comparison of a Tissue Perfusion Guided Hemodynamic Protocol With a Standard Hemodynamic Protocol in Septic Shock Patients
NCT01296789 ·Status: TERMINATED ·Phase: NA
-
Evaluating the Effect of Chronic Antihypertensive Therapy on Vasopressor Dosing in Septic Shock
NCT02884011 ·Status: COMPLETED
-
The Effect of Vasopressor Therapy on Renal Perfusion in Septic Shock
NCT06234592 ·Status: RECRUITING ·Phase: NA
-
Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis
NCT05681442 ·Status: RECRUITING ·Phase: PHASE4
-
Predict Sepsis; the Predictive Value of Bedside Measures in the Ambulance
NCT03249597 ·Status: COMPLETED
-
Early Albumin Resuscitation During Septic Shock
NCT00327704 ·Status: COMPLETED ·Phase: PHASE4